Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study

Shinichi Sakamoto1 Department of Ophthalmology, Jichi Medical University, Shimotsuke-shi, Tochigi, Japan, [email protected]

Hidenori Takahashi1 Department of Ophthalmology, Jichi Medical University, Shimotsuke-shi, Tochigi, Japan, [email protected];2 Department of Ophthalmology, Japan Community Health Care Organization Tokyo Shinjuku Medical Center, Tokyo, Japan, [email protected]Correspondence[email protected]

Yuji Inoue1 Department of Ophthalmology, Jichi Medical University, Shimotsuke-shi, Tochigi, Japan, [email protected]

Yusuke Arai1 Department of Ophthalmology, Jichi Medical University, Shimotsuke-shi, Tochigi, Japan, [email protected]

Satoru Inoda1 Department of Ophthalmology, Jichi Medical University, Shimotsuke-shi, Tochigi, Japan, [email protected]

Natsuko Kakinuma2 Department of Ophthalmology, Japan Community Health Care Organization Tokyo Shinjuku Medical Center, Tokyo, Japan, [email protected]

Yujiro Fujino2 Department of Ophthalmology, Japan Community Health Care Organization Tokyo Shinjuku Medical Center, Tokyo, Japan, [email protected]

Tatsuro Tanabe2 Department of Ophthalmology, Japan Community Health Care Organization Tokyo Shinjuku Medical Center, Tokyo, Japan, [email protected]

Hidetoshi Kawashima1 Department of Ophthalmology, Jichi Medical University, Shimotsuke-shi, Tochigi, Japan, [email protected]

Yasuo Yanagi3 Medical Retina, Singapore National Eye Centre, Singapore;4 Medical Retina, Singapore Eye Research Institute, Singapore;5 Eye-ACP, Duke NUS Medical School, National University of Singapore, Singapore

show all

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (6)

Tianyang Zhou, Xiang LiJingjing YangHuiyun XiaQian LiuJijun HeJunjie Zhang. (2023) Ocular Pharmacokinetic Properties of Intravitreally Injected Aflibercept in Rabbits After Using Brinzolamide/Timolol Eye Drops. Journal of Ocular Pharmacology and Therapeutics 39:3, pages 229-234.
Crossref

Kenji Yamashiro, Yasuo Yanagi, Hideki Koizumi, Hidetaka Matsumoto, Chui Ming Gemmy Cheung, Fumi Gomi, Tomohiro Iida & Akitaka Tsujikawa. (2022) Relationship between Pachychoroid and Polypoidal Choroidal Vasculopathy. Journal of Clinical Medicine 11:15, pages 4614.
Crossref

Annabelle A. Okada, Kanji Takahashi, Masahito Ohji, SungChul Charles Moon, Tobias Machewitz, Koji Sasaki, Masahito Ohji, Tsukasa Hanemoto, Tatsushi Kaga, Takeya Kouno, Hirokuni Kitamei, Shinpei Sato, Kanji Takahashi, Ryoji Yanai, Eiichi Uchio, Kazunori Miyata, Yoshihiro Wakabayashi, Takatoshi Maeno, Tsutomu Yasukawa, Masayuki Horiguchi, Tetsuya Nishimura, Akiteru Kawahara, Yasuo Kurimoto, Kenichi Murai, Namie Kobayashi, Wataru Kimura, Eriko Matsushita, Tomohiro Iida, Kanako Yasuda, Masahiro Miura, Annabelle Ayame Okada, Ryusaburo Mori, Atsushi Sugiyama, Yasuo Ito, Daisaku Kimura, Kei Nakai, Chota Matsumoto, Shinobu Takeuchi, Kishiko Okoshi, Yoshihisa Nuno, Yohei Nomoto, Toshio Mori, Muneyasu Takeda, Noriko Yoshida, Mio Hosokawa & Kohei Sonoda. (2022) Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup. Advances in Therapy 39:6, pages 2984-2998.
Crossref

Vincent Daien, Robert P Finger, James S Talks, Paul Mitchell, Tien Y Wong, Taiji Sakamoto, Bora M Eldem & Jean-François Korobelnik. (2021) Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence. British Journal of Ophthalmology 105:11, pages 1475-1479.
Crossref

Ji Min Kwon, Kang Yeun Pak, Jae Jung Lee, Min Sagong & Hyun Woong Kim. (2021) One-year Results of Aflibercept Treatment for Polypoidal Choroidal Vasculopathy with Good Visual Acuity. Korean Journal of Ophthalmology 35:1, pages 26-36.
Crossref

Ichiro Maruko, Masashi Ogasawara, Akiko Yamamoto, Kanako Itagaki, Taiji Hasegawa, Hisaya Arakawa, Makiko Nakayama, Hideki Koizumi, Annabelle A. Okada, Tetsuju Sekiryu & Tomohiro Iida. (2020) Two-Year Outcomes of Treat-and-Extend Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration. Ophthalmology Retina 4:8, pages 767-776.
Crossref

Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study

Articles from other publishers (6)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study

Citations (6)

Articles from other publishers (6)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date